4//SEC Filing
OXYGEN BIOTHERAPEUTICS, INC. 4
Accession 0001354488-13-006458
$TENXCIK 0000034956operating
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 4:31 PM ET
Size
6.4 KB
Accession
0001354488-13-006458
Insider Transaction Report
Form 4
Kelley John P
Chief Executive Officer
Transactions
- Award
Series E Preferred Stock
2013-11-13+8,248→ 8,248 total - Award
Common Stock
2013-11-13+341,711→ 341,711 total
Footnotes (2)
- [F1]The reporting person acquired the securities in connection with the sale of substantially all assets of Phyxius Pharma, Inc. to a wholly owned subsidiary of Oxygen Biotherapeutics, Inc. (the "Transaction").
- [F2]In connection with the Transaction, 1,749 shares of the reporting person?s Series E Preferred Stock are being held in escrow to satisfy indemnification obligations.
Documents
Issuer
OXYGEN BIOTHERAPEUTICS, INC.
CIK 0000034956
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000034956
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 4:31 PM ET
- Size
- 6.4 KB